{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T14:21:48Z","timestamp":1789741308044,"version":"4.0.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004761","name":"the Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["2022JJ30879"],"award-info":[{"award-number":["2022JJ30879"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004761","name":"the Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["2024JJ5509"],"award-info":[{"award-number":["2024JJ5509"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Hunan Innovative Province Construction Project","award":["2023SK2037"],"award-info":[{"award-number":["2023SK2037"]}]},{"DOI":"10.13039\/501100001809","name":"the Program of the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81971086"],"award-info":[{"award-number":["81971086"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Genom. Med."],"DOI":"10.1038\/s41525-025-00531-2","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T13:13:24Z","timestamp":1763730804000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Characterization of the genetic and clinical landscapes of DCTN1 gene in neurodegenerative diseases: a series of large case-control study"],"prefix":"10.1038","volume":"10","author":[{"given":"Xiaorong","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuxiong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwei","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhineng","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beisha","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifang","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"531_CR1","doi-asserted-by":"publisher","first-page":"101069","DOI":"10.1016\/j.arr.2020.101069","volume":"61","author":"D Lee","year":"2020","unstructured":"Lee, D., Choi, Y. H., Seo, J., Kim, J. K. & Lee, S. B. Discovery of new epigenomics-based biomarkers and the early diagnosis of neurodegenerative diseases. Ageing Res. Rev. 61, 101069 (2020).","journal-title":"Ageing Res. Rev."},{"key":"531_CR2","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/nature20411","volume":"539","author":"T Wyss-Coray","year":"2016","unstructured":"Wyss-Coray, T. Ageing, neurodegeneration and brain rejuvenation. Nature 539, 180\u2013186 (2016).","journal-title":"Nature"},{"key":"531_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13024-022-00524-0","volume":"17","author":"LK Wareham","year":"2022","unstructured":"Wareham, L. K. et al. Solving neurodegeneration: common mechanisms and strategies for new treatments. Mol. Neurodegener. 17, 23 (2022).","journal-title":"Mol. Neurodegener."},{"key":"531_CR4","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1136\/jnnp-2017-316988","volume":"89","author":"GK Tofaris","year":"2018","unstructured":"Tofaris, G. K. & Buckley, N. J. Convergent molecular defects underpin diverse neurodegenerative diseases. J. Neurol. Neurosurg. Psychiatry 89, 962\u2013969 (2018).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"531_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00401-004-0952-x","volume":"109","author":"S Roy","year":"2005","unstructured":"Roy, S., Zhang, B., Lee, V. M. & Trojanowski, J. Q. Axonal transport defects: a common theme in neurodegenerative diseases. Acta Neuropathol. 109, 5\u201313 (2005).","journal-title":"Acta Neuropathol."},{"key":"531_CR6","doi-asserted-by":"publisher","unstructured":"Berth, S. H. & Lloyd, T. E. Disruption of axonal transport in neurodegeneration. J. Clin. Invest. 133 https:\/\/doi.org\/10.1172\/jci168554 (2023).","DOI":"10.1172\/jci168554"},{"key":"531_CR7","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1146\/annurev.cellbio.20.012103.094623","volume":"20","author":"TA Schroer","year":"2004","unstructured":"Schroer, T. A. Dynactin. Annu Rev. Cell Dev. Biol. 20, 759\u2013779 (2004).","journal-title":"Annu Rev. Cell Dev. Biol."},{"key":"531_CR8","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1126\/science.aaa4080","volume":"347","author":"L Urnavicius","year":"2015","unstructured":"Urnavicius, L. et al. The structure of the dynactin complex and its interaction with dynein. Science 347, 1441\u20131446 (2015).","journal-title":"Science"},{"key":"531_CR9","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/ng1123","volume":"33","author":"I Puls","year":"2003","unstructured":"Puls, I. et al. Mutant dynactin in motor neuron disease. Nat. Genet 33, 455\u2013456 (2003).","journal-title":"Nat. Genet"},{"key":"531_CR10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/ng.293","volume":"41","author":"MJ Farrer","year":"2009","unstructured":"Farrer, M. J. et al. DCTN1 mutations in Perry syndrome. Nat. Genet 41, 163\u2013165 (2009).","journal-title":"Nat. Genet"},{"key":"531_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14802\/jmd.20060","volume":"14","author":"Y Tsuboi","year":"2021","unstructured":"Tsuboi, Y., Mishima, T. & Fujioka, S. Perry disease: concept of a new disease and clinical diagnostic criteria. J. Mov. Disord. 14, 1\u20139 (2021).","journal-title":"J. Mov. Disord."},{"key":"531_CR12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.parkreldis.2008.07.005","volume":"15","author":"C Wider","year":"2009","unstructured":"Wider, C. et al. Pallidonigral TDP-43 pathology in Perry syndrome. Parkinsonism Relat. Disord. 15, 281\u2013286 (2009).","journal-title":"Parkinsonism Relat. Disord."},{"key":"531_CR13","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/jnen\/nlx049","volume":"76","author":"T Mishima","year":"2017","unstructured":"Mishima, T. et al. Perry syndrome: a distinctive type of TDP-43 proteinopathy. J. Neuropathol. Exp. Neurol. 76, 676\u2013682 (2017).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"531_CR14","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/ana.20631","volume":"58","author":"C M\u00fcnch","year":"2005","unstructured":"M\u00fcnch, C. et al. Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD. Ann. Neurol. 58, 777\u2013780 (2005).","journal-title":"Ann. Neurol."},{"key":"531_CR15","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1212\/WNL.0b013e3181a92c4c","volume":"72","author":"C Vilari\u00f1o-G\u00fcell","year":"2009","unstructured":"Vilari\u00f1o-G\u00fcell, C. et al. Characterization of DCTN1 genetic variability in neurodegeneration. Neurology 72, 2024\u20132028 (2009).","journal-title":"Neurology"},{"key":"531_CR16","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1001\/jamaneurol.2013.5100","volume":"71","author":"P Caroppo","year":"2014","unstructured":"Caroppo, P. et al. DCTN1 mutation analysis in families with progressive supranuclear palsy-like phenotypes. JAMA Neurol. 71, 208\u2013215 (2014).","journal-title":"JAMA Neurol."},{"key":"531_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.parkreldis.2016.04.025","volume":"28","author":"EK Gustavsson","year":"2016","unstructured":"Gustavsson, E. K. et al. DCTN1 p.K56R in progressive supranuclear palsy. Parkinsonism Relat. Disord. 28, 56\u201361 (2016).","journal-title":"Parkinsonism Relat. Disord."},{"key":"531_CR18","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41531-023-00518-9","volume":"9","author":"YM Sun","year":"2023","unstructured":"Sun, Y. M. et al. The genetic spectrum of a cohort of patients clinically diagnosed as Parkinson\u2019s disease in mainland China. NPJ Parkinsons Dis. 9, 76 (2023).","journal-title":"NPJ Parkinsons Dis."},{"key":"531_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41531-023-00478-0","volume":"9","author":"J Yu","year":"2023","unstructured":"Yu, J. et al. Deficiency of Perry syndrome-associated p150(Glued) in midbrain dopaminergic neurons leads to progressive neurodegeneration and endoplasmic reticulum abnormalities. NPJ Parkinsons Dis. 9, 35 (2023).","journal-title":"NPJ Parkinsons Dis."},{"key":"531_CR20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13024-018-0242-z","volume":"13","author":"J Yu","year":"2018","unstructured":"Yu, J. et al. Genetic ablation of dynactin p150(Glued) in postnatal neurons causes preferential degeneration of spinal motor neurons in aged mice. Mol. Neurodegener. 13, 10 (2018).","journal-title":"Mol. Neurodegener."},{"key":"531_CR21","doi-asserted-by":"publisher","unstructured":"Deshimaru, M. et al. DCTN1 Binds to TDP-43 and Regulates TDP-43 Aggregation. Int. J. Mol. Sci. 22 https:\/\/doi.org\/10.3390\/ijms22083985 (2021).","DOI":"10.3390\/ijms22083985"},{"key":"531_CR22","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/ana.24346","volume":"77","author":"JC Steele","year":"2015","unstructured":"Steele, J. C. et al. Defining neurodegeneration on Guam by targeted genomic sequencing. Ann. Neurol. 77, 458\u2013468 (2015).","journal-title":"Ann. Neurol."},{"key":"531_CR23","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1136\/jnnp-2018-319838","volume":"90","author":"M Ryan","year":"2019","unstructured":"Ryan, M. et al. Comparison of the clinical and genetic features of amyotrophic lateral sclerosis across Cuban, Uruguayan and Irish clinic-based populations. J. Neurol. Neurosurg. Psychiatry 90, 659\u2013665 (2019).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"531_CR24","doi-asserted-by":"publisher","first-page":"143.e145","DOI":"10.1016\/j.neurobiolaging.2020.04.006","volume":"93","author":"R Procopio","year":"2020","unstructured":"Procopio, R. et al. DCTN1 mutation analysis in Italian patients with PSP, MSA, and DLB. Neurobiol. Aging 93, 143.e145\u2013143 (2020).","journal-title":"Neurobiol. Aging"},{"key":"531_CR25","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s41431-020-00767-9","volume":"29","author":"R Borg","year":"2021","unstructured":"Borg, R. et al. Genetic analysis of ALS cases in the isolated island population of Malta. Eur. J. Hum. Genet. 29, 604\u2013614 (2021).","journal-title":"Eur. J. Hum. Genet."},{"key":"531_CR26","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nrn3380","volume":"14","author":"S Millecamps","year":"2013","unstructured":"Millecamps, S. & Julien, J. P. Axonal transport deficits and neurodegenerative diseases. Nat. Rev. Neurosci. 14, 161\u2013176 (2013).","journal-title":"Nat. Rev. Neurosci."},{"key":"531_CR27","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1093\/hmg\/ddn014","volume":"17","author":"B Ebbing","year":"2008","unstructured":"Ebbing, B. et al. Effect of spastic paraplegia mutations in KIF5A kinesin on transport activity. Hum. Mol. Genet. 17, 1245\u20131252 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"531_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6245","volume":"5","author":"VK Godena","year":"2014","unstructured":"Godena, V. K. et al. Increasing microtubule acetylation rescues axonal transport and locomotor deficits caused by LRRK2 Roc-COR domain mutations. Nat. Commun. 5, 5245 (2014).","journal-title":"Nat. Commun."},{"key":"531_CR29","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1038\/nn.2660","volume":"13","author":"DA Bosco","year":"2010","unstructured":"Bosco, D. A. et al. Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat. Neurosci. 13, 1396\u20131403 (2010).","journal-title":"Nat. Neurosci."},{"key":"531_CR30","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.1111\/ene.15048","volume":"28","author":"J Dulski","year":"2021","unstructured":"Dulski, J. et al. Clinical, pathological and genetic characteristics of Perry disease-new cases and literature review. Eur. J. Neurol. 28, 4010\u20134021 (2021).","journal-title":"Eur. J. Neurol."},{"key":"531_CR31","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.parkreldis.2017.06.004","volume":"41","author":"T Konno","year":"2017","unstructured":"Konno, T. et al. DCTN1-related neurodegeneration: Perry syndrome and beyond. Parkinsonism Relat. Disord. 41, 14\u201324 (2017).","journal-title":"Parkinsonism Relat. Disord."},{"key":"531_CR32","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.parkreldis.2020.06.006","volume":"77","author":"M \u010cierny","year":"2020","unstructured":"\u010cierny, M. et al. Novel destabilizing Dynactin variant (DCTN1 p.Tyr78His) in patient with Perry syndrome. Parkinsonism Relat. Disord. 77, 110\u2013113 (2020).","journal-title":"Parkinsonism Relat. Disord."},{"key":"531_CR33","doi-asserted-by":"publisher","first-page":"6667","DOI":"10.1007\/s00415-022-11308-3","volume":"269","author":"TB Stoker","year":"2022","unstructured":"Stoker, T. B. et al. DCTN1 mutation associated parkinsonism: case series of three new families with perry syndrome. J. Neurol. 269, 6667\u20136672 (2022).","journal-title":"J. Neurol."},{"key":"531_CR34","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00401-012-1013-5","volume":"124","author":"H Houlden","year":"2012","unstructured":"Houlden, H. & Singleton, A. B. The genetics and neuropathology of Parkinson\u2019s disease. Acta Neuropathol. 124, 325\u2013338 (2012).","journal-title":"Acta Neuropathol."},{"key":"531_CR35","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1080\/21678421.2021.1918722","volume":"23","author":"J He","year":"2022","unstructured":"He, J., Yu, W., Liu, X. & Fan, D. An identical DCTN1 mutation in two Chinese siblings manifest as dHMN and ALS respectively: a case report. Amyotroph. Lateral Scler. Frontotemp. Degener. 23, 149\u2013153 (2022).","journal-title":"Amyotroph. Lateral Scler. Frontotemp. Degener."},{"key":"531_CR36","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft, C. et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 562, 203\u2013209 (2018).","journal-title":"Nature"},{"key":"531_CR37","doi-asserted-by":"publisher","first-page":"118826","DOI":"10.1016\/j.lfs.2020.118826","volume":"265","author":"E Akyuz","year":"2021","unstructured":"Akyuz, E. et al. Revisiting the role of neurotransmitters in epilepsy: an updated review. Life Sci. 265, 118826 (2021).","journal-title":"Life Sci."},{"key":"531_CR38","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.14336\/AD.2019.0215","volume":"10","author":"ZJ Liu","year":"2019","unstructured":"Liu, Z. J. et al. Genetic Spectrum and Variability in Chinese Patients with Amyotrophic Lateral Sclerosis. Aging Dis. 10, 1199\u20131206 (2019).","journal-title":"Aging Dis."},{"key":"531_CR39","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1111\/j.1600-0854.2009.00976.x","volume":"10","author":"ON Zhapparova","year":"2009","unstructured":"Zhapparova, O. N. et al. Dynactin subunit p150Glued isoforms notable for differential interaction with microtubules. Traffic 10, 1635\u20131646 (2009).","journal-title":"Traffic"},{"key":"531_CR40","doi-asserted-by":"publisher","first-page":"4807","DOI":"10.1038\/ncomms5807","volume":"5","author":"S Ayloo","year":"2014","unstructured":"Ayloo, S. et al. Dynactin functions as both a dynamic tether and brake during dynein-driven motility. Nat. Commun. 5, 4807 (2014).","journal-title":"Nat. Commun."},{"key":"531_CR41","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1002\/mds.29037","volume":"37","author":"X Zhou","year":"2022","unstructured":"Zhou, X. et al. The Chinese Parkinson\u2019s Disease Registry (CPDR): study design and baseline patient characteristics. Mov. Disord. 37, 1335\u20131345 (2022).","journal-title":"Mov. Disord."},{"key":"531_CR42","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1136\/jnnp-2017-316864","volume":"89","author":"T Mishima","year":"2018","unstructured":"Mishima, T. et al. Establishing diagnostic criteria for Perry syndrome. J. Neurol. Neurosurg. Psychiatry 89, 482\u2013487 (2018).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"531_CR43","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma, R. B. et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov. Disord. 30, 1591\u20131601 (2015).","journal-title":"Mov. Disord."},{"key":"531_CR44","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/j.clinph.2020.04.005","volume":"131","author":"JM Shefner","year":"2020","unstructured":"Shefner, J. M. et al. A proposal for new diagnostic criteria for ALS. Clin. Neurophysiol. 131, 1975\u20131978 (2020).","journal-title":"Clin. Neurophysiol."},{"key":"531_CR45","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1038\/s41431-018-0177-4","volume":"26","author":"Project MinE","year":"2018","unstructured":"Project MinE study design and pilot analyses of a large-scale whole-genome sequencing study in amyotrophic lateral sclerosis. Eur. J. Hum. Genet. 26, 1537\u20131546 (2018).","journal-title":"Eur. J. Hum. Genet."},{"key":"531_CR46","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s41586-021-04103-z","volume":"599","author":"JD Backman","year":"2021","unstructured":"Backman, J. D. et al. Exome sequencing and analysis of 454,787 UK Biobank participants. Nature 599, 628\u2013634 (2021).","journal-title":"Nature"},{"key":"531_CR47","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41531-025-00901-8","volume":"11","author":"J Yang","year":"2025","unstructured":"Yang, J. et al. A PheWAS approach to identify associations of GBA1 variants with comprehensive phenotypes beyond neurological diseases. NPJ Parkinsons Dis. 11, 48 (2025).","journal-title":"NPJ Parkinsons Dis."},{"key":"531_CR48","doi-asserted-by":"publisher","unstructured":"Zhao, Y. et al. Expanding the Autosomal recessive gene spectrum of Parkinson\u2019s Disease: a study within the CPD10KGP. Mov. Disord. https:\/\/doi.org\/10.1002\/mds.70039 (2025).","DOI":"10.1002\/mds.70039"},{"key":"531_CR49","doi-asserted-by":"publisher","first-page":"5443","DOI":"10.1007\/s12035-022-02920-5","volume":"59","author":"K Zhang","year":"2022","unstructured":"Zhang, K. et al. Genetic analysis of HSP40\/DNAJ family genes in Parkinson\u2019s disease: a large case-control study. Mol. Neurobiol. 59, 5443\u20135451 (2022).","journal-title":"Mol. Neurobiol."},{"key":"531_CR50","doi-asserted-by":"publisher","first-page":"1229491","DOI":"10.3389\/fnagi.2023.1229491","volume":"15","author":"Y Wen","year":"2023","unstructured":"Wen, Y. et al. Clinical features of progressive supranuclear palsy. Front. Aging Neurosci. 15, 1229491 (2023).","journal-title":"Front. Aging Neurosci."},{"key":"531_CR51","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang, K., Li, M. & Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38, e164 (2010).","journal-title":"Nucleic Acids Res."},{"key":"531_CR52","doi-asserted-by":"publisher","first-page":"D1039","DOI":"10.1093\/nar\/gkx1039","volume":"46","author":"J Li","year":"2018","unstructured":"Li, J. et al. VarCards: an integrated genetic and clinical database for coding variants in the human genome. Nucleic Acids Res. 46, D1039\u2013d1048 (2018).","journal-title":"Nucleic Acids Res."},{"key":"531_CR53","doi-asserted-by":"publisher","first-page":"749109","DOI":"10.3389\/fnagi.2021.749109","volume":"13","author":"YW Zhao","year":"2021","unstructured":"Zhao, Y. W. et al. The Association between lysosomal storage disorder genes and Parkinson\u2019s disease: a large cohort study in Chinese mainland population. Front. Aging Neurosci. 13, 749109 (2021).","journal-title":"Front. Aging Neurosci."},{"key":"531_CR54","doi-asserted-by":"publisher","first-page":"7793","DOI":"10.1093\/nar\/gky678","volume":"46","author":"J Li","year":"2018","unstructured":"Li, J. et al. Performance evaluation of pathogenicity-computation methods for missense variants. Nucleic Acids Res. 46, 7793\u20137804 (2018).","journal-title":"Nucleic Acids Res."},{"key":"531_CR55","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1002\/sim.7273","volume":"36","author":"R Puhr","year":"2017","unstructured":"Puhr, R., Heinze, G., Nold, M., Lusa, L. & Geroldinger, A. Firth\u2019s logistic regression with rare events: accurate effect estimates and predictions?. Stat. Med. 36, 2302\u20132317 (2017).","journal-title":"Stat. Med."},{"key":"531_CR56","doi-asserted-by":"publisher","first-page":"W420","DOI":"10.1093\/nar\/gkac373","volume":"50","author":"Y Xie","year":"2022","unstructured":"Xie, Y. et al. IBS 2.0: an upgraded illustrator for the visualization of biological sequences. Nucleic Acids Res. 50, W420\u2013w426 (2022).","journal-title":"Nucleic Acids Res."}],"container-title":["npj Genomic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41525-025-00531-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41525-025-00531-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41525-025-00531-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T14:04:13Z","timestamp":1763733853000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41525-025-00531-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["531"],"URL":"https:\/\/doi.org\/10.1038\/s41525-025-00531-2","relation":{},"ISSN":["2056-7944"],"issn-type":[{"value":"2056-7944","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"27 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"75"}}